Amoxicillin/Clavulanic acid Actavis 500 mg/125 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

amoxicillin/clavulanic acid actavis 500 mg/125 mg apvalkotās tabletes

teva b.v., netherlands - amoxicillinum, skābes clavulanicum - apvalkotā tablete - 500 mg/125 mg

Byannli (previously Paliperidone Janssen-Cilag International) Eiropas Savienība - latviešu - EMA (European Medicines Agency)

byannli (previously paliperidone janssen-cilag international)

janssen-cilag international n.v.   - paliperidona palmitāts - Šizofrēnija - psihoterapija - byannli (previously paliperidone janssen-cilag international) a 6 monthly injection, is indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1 monthly or 3 monthly paliperidone palmitate injectable products (see section 5.

Abiraterone Accord Eiropas Savienība - latviešu - EMA (European Medicines Agency)

abiraterone accord

accord healthcare s.l.u. - abiraterona acetāts - prostatas audzēji - endokrīnā terapija - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Celsunax Eiropas Savienība - latviešu - EMA (European Medicines Agency)

celsunax

pinax pharma gmbh - ioflupane (123i) - radionuclide imaging; dementia; movement disorders - diagnostikas radiofarmaceitiskie preparāti - Šīs zāles ir paredzētas tikai diagnostikas vajadzībām. celsunax is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum:in adult patients with clinically uncertain parkinsonian syndromes, for example those with early symptoms, in order to help differentiate essential tremor from parkinsonian syndromes related to idiopathic parkinson’s disease, multiple system atrophy and progressive supranuclear palsy.  celsunax is unable to discriminate between parkinson's disease, multiple system atrophy and progressive supranuclear palsy. pieaugušo pacientu, lai palīdzētu atšķirt ticams, demence ar lewy iestādēm, no alcheimera slimības.  celsunax is unable to discriminate between dementia with lewy bodies and parkinson’s disease dementia.

Abiraterone Mylan Eiropas Savienība - latviešu - EMA (European Medicines Agency)

abiraterone mylan

mylan ireland limited - abiraterona acetāts - prostatas audzēji - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Abiraterone Krka Eiropas Savienība - latviešu - EMA (European Medicines Agency)

abiraterone krka

krka, d.d., novo mesto - abiraterona acetāts - prostatas audzēji - endokrīnā terapija - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Voraxaze Eiropas Savienība - latviešu - EMA (European Medicines Agency)

voraxaze

serb sas - glikarpidāze - metabolic side effects of drugs and substances - visi pārējie terapeitiskie produkti - voraxaze is indicated to reduce toxic plasma methotrexate concentration in adults and children (aged 28 days and older) with delayed methotrexate elimination or at risk of methotrexate toxicity.

Adasuve Eiropas Savienība - latviešu - EMA (European Medicines Agency)

adasuve

ferrer internacional s.a. - loxapine - schizophrenia; bipolar disorder - nervu sistēma - adasuve ir norādīts ātri kontroles vieglas līdz vidēji satraukumu pieaugušiem pacientiem ar å ¡izofrä " nijas vai bipolāri traucējumi. pacienti regulāri jāārstē tūlīt pēc akūtas uzbudinājuma simptomu kontroles.